Bar Plot from Scientific Research

Waterfall plots of pathologic tumor regression (percentage reduction of viable tumor cells) in resected tumors and lymph nodes following neoadjuvant treatment with nivolumab (arm A, blue) or nivolumab and relatlimab (arm B, red). The color intensity encodes the category of PD-L1 expression by tumor cells (TPS <1% light color, TPS 1–49% medium dark color, TPS 50–100% dark color). The lower panel depicts the oncogram of each tumor using next-generation DNA sequencing of 500 cancer-related genes. Boxes represent pathogenic genomic aberrations in the respective gene. Genes with pathogenic aberrations in at least two study patients are listed.

DOI